You are here

Interviews

Top 10 tips from entrepreneurs in the BioRegion

More than 50 interviews with entrepreneurs and 5 years of Startup Generation make for many insights, anecdotes and experiences. We have compiled some of them in this top ten so that they can serve you as inspiration.

Clara Campàs (Asabys Partners): “Society’s growing interest in science due to Covid-19 could boost investment in healthcare”

Clara Campàs, partner and co-founder of specialized venture capital fund Asabys Partners, analyzes how the global Covid-19 crisis is affecting the sector and is optimistic about the future of investment in healthcare.

Joël Jean-Mairet (Ysios Capital): “The Covid-19 crisis has to remind us of the need to innovate in the life sciences”

Joël Jean-Mairet, managing partner of Ysios Capital, explained how he sees this crisis from the perspective of a venture capital fund and warns that continued investment in healthcare innovation is more necessary than ever.

Marta-Gaia Zanchi (Nina Capital): “This year we will see lower investment in health technology concentrated in fewer deals”

Dr. Marta-Gaia Zanchi, founder and managing partner of Nina Capital, explains how the Covid-19 pandemic could affect investment in digital health and medical technology.

Montserrat Vendrell (Alta Life Sciences): "Covid-19 is opening a lot of doors for business and investment opportunities in the healthcare sector”

Montserrat Vendrell, partner in the Alta Life Sciences investment fund, explains how investors are experiencing the Covid-19 pandemic and highlights one of the few positives that may come out of this crisis: new opportunities in the healthcare sector.

Lluís Pareras (Invivo Ventures): “Stopping now would be a mistake”

Lluís Pareras, founding partner of the new fund Invivo Ventures, is optimistic about the future of the life sciences sector and warns that companies need to keep working at a good pace these months so they don’t lose inertia.

Jordi Naval
26.09.2018

Jordi Naval

CEO of Biocat

Jordi Naval (Barcelona, ​​1969) holds a degree in Pharmacy from the University of Barcelona (UB) and a degree in Biochemistry from the Autonomous University of Barcelona (UAB). Over the past 18 years Naval has been involved in the creation of several start-ups (Infociencia, Anaxomics, Enemce Pharma, Genocosmetics Lab and Aelix Therapeutics) and was Director of the Bosch i Gimpera Foundation between 2015 and 2017 and President of the Escola d'Emprendedors Foundation from 2010 to 2017. He was appointed new CEO of Biocat last July. 

Marta Gaia Stanford Biocat digital health barcelona biodesign moebio
29.05.2018

Marta Gaia

Director of Digital Health at Stanford Byers Center of Biodesign

Marta Gaia holds degrees in Biomedical Engineering and Electrical Engineering from Politecnico Di Milano, Italy (BS, MS) and Stanford University (PhD), and a certificate in Entrepreneurship from the Stanford Graduate School of Business. In 2016, the Silicon Valley Business Journal named her one of the 'Silicon Valley 40 Under 40'.

Sylvie Bove, EIT Health
26.10.2017

Sylvie Bove

CEO of EIT Health

From pharmaceuticals to innovation in Europe: in 2015 French-born Sylvie Bove was named CEO of EIT Health, the first European initiative to promote European leadership and competitiveness in health innovation. Bove has 20 years experience managing and directing companies in the field of life sciences. She has overseen the launch of new products while working with large companies in the healthcare sector, such as Coloplast and Ferring Pharmaceuticals, and she helped found the Copenhagen Healthtech Cluster.

Joseph Damond
20.07.2017

Joseph Damond

Executive Vice President for International Affairs at the Biotechnology Innovation Organization (BIO)

Mr. Damond is responsible for developing and implementing the industry association’s international advocacy and outreach program, including the areas of trade policy and foreign government relations. Prior to taking up this position at BIO, Mr. Damond was vice president for International Government Relations in Pfizer’s Washington office from 2006-2011.